
Company Updates
Breath Biopsy
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, today announced the close of its Series D financing round, securing $58 million and bringing the total raised by the company to over $150 million since founding in 2016.
Company Updates
COVID-19
Breath Biopsy
Breath Biopsy
Company Updates
Breath Biopsy
Breath Biopsy
Company Updates
Company Updates
Breath Biopsy
Breath Biopsy
Breath Biopsy